A history of drug development in four acts

Michael S. Kinch; Denton Hoyer

doi:10.1016/j.drudis.2015.04.003

A history of drug development in four acts

Michael S. Kinch, Denton Hoyer

Research output: Contribution to journal › Short survey › peer-review

Original language	English
Article number	1609
Pages (from-to)	1163-1168
Number of pages	6
Journal	Drug Discovery Today
Volume	20
Issue number	10
DOIs	https://doi.org/10.1016/j.drudis.2015.04.003
State	Published - Oct 1 2015

Access to Document

10.1016/j.drudis.2015.04.003

Cite this

@article{51abefb9dd95408f9d7c1f70c55a255e,

title = "A history of drug development in four acts",

author = "Kinch, {Michael S.} and Denton Hoyer",

note = "Funding Information: The Bayh–Dole Act of 1980 triggered a period of change [21,22] . The legislation allowed universities to own inventions arising from Federal-funded research and obligated academic inventors to assign their inventive rights to the university. These changes accelerated the growth of biotechnology and incentivized {\textquoteleft}spin-out{\textquoteright} companies based on university research. Many universities embraced translation by expanding their research infrastructure (e.g. creating drug screening facilities) that had exclusively been in the realm of the private sector. This growth was paid for, in part, by increasing levels of external support (e.g. NIH grants) and, occasionally, from patent revenues. ",

year = "2015",

month = oct,

day = "1",

doi = "10.1016/j.drudis.2015.04.003",

language = "English",

volume = "20",

pages = "1163--1168",

journal = "Drug Discovery Today",

issn = "1359-6446",

number = "10",

}

TY - JOUR

T1 - A history of drug development in four acts

AU - Kinch, Michael S.

AU - Hoyer, Denton

N1 - Funding Information: The Bayh–Dole Act of 1980 triggered a period of change [21,22] . The legislation allowed universities to own inventions arising from Federal-funded research and obligated academic inventors to assign their inventive rights to the university. These changes accelerated the growth of biotechnology and incentivized ‘spin-out’ companies based on university research. Many universities embraced translation by expanding their research infrastructure (e.g. creating drug screening facilities) that had exclusively been in the realm of the private sector. This growth was paid for, in part, by increasing levels of external support (e.g. NIH grants) and, occasionally, from patent revenues.

PY - 2015/10/1

Y1 - 2015/10/1

UR - http://www.scopus.com/inward/record.url?scp=84944441363&partnerID=8YFLogxK

U2 - 10.1016/j.drudis.2015.04.003

DO - 10.1016/j.drudis.2015.04.003

M3 - Short survey

C2 - 25908577

AN - SCOPUS:84944441363

SN - 1359-6446

VL - 20

SP - 1163

EP - 1168

JO - Drug Discovery Today

JF - Drug Discovery Today

IS - 10

M1 - 1609

ER -

A history of drug development in four acts

Access to Document

Other files and links

Cite this